Targeted next-generation sequencing for mutational screening in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation within a clinical setting

V. Ljungstrom , Šárka Pospíšilová , Jitka Malčíková , Martin Trbušek
19th Congress of the European-Hematology-Association, JUN 12-15, 2014, Milan, ITALY 99 313 -314

2014
Not All IGHV3-21 CLL Are Equal : Subset #2 Displays a Distinctive Clinicobiological Profile with Remarkable Similarities to Subset #169, its Close Immunogenetic Relative

A. Hadzidimitriou , F. Nguyen-Khac , T. Shanafelt , S. Pospisilova
19th Congress of the European-Hematology-Association, JUN 12-15, 2014, Milan, ITALY 99 48 -49

2014
Immunoglobulin Heavy Chain Variable Genes and Alleles: New Entities, New Names and Implications for Research and Prognostication in CLL

A. Hadzidimitriou , I. Vlahavas , I. Chouvarda , Richard Brandell Rosenquist
Haematologica 99 49 -49

2014
Skewing of the T-Cell Receptor Repertoire in Chronic Lymphocytic Leukemia : What Lies Beneath?

A. Hadzidimitriou , E. Stalika , Richard Brandell Rosenquist , M. Karypidou
19th Congress of the European-Hematology-Association, JUN 12-15, 2014, Milan, ITALY 99 41 -41

2014
A screening study of Chlamydia psittaci infection in 172 cases of nodal and extranodal non-hodgkin lymphomas

M. G. Cangi , M. Guidoboni , L. Pecciarini , R. Dolcetti
Haematologica-the Hematology Journal 92 8 -8

2007
Exposure to Animals and Risk of Ocular Adnexal Marginal Zone B-Cell Lymphoma

S. Govi , D. Serraino , R. Dolcetti , C. Doglioni
Annals of Oncology 22 142 -142

2011
Identification of novel B cell receptor antigens in chronic lymphocytic leukemia.

A. Ferrajoli , Z. Estrov , W. G. Wierda , H. Urlaub
21st Congress of the European-Hematology-Association 45 -45

2016
Dissecting the natural history of chronic lymphocytic leukemia to discover new therapeutic targets

F. Caligaris-Cappio , M. Frenquelli , A. Camporeale , A. Bachi
Haematologica Reports 2 ( 7) 27 -29

2006
CLL: Different ages, dfferent antigen receptor profiles

A. Hadzidimitriou , Šárka Pospíšilová , Boris Tichý , R. Rosenquist

1
2013
2013
IDELALISIB EFFICACY AND SAFETY IN FOLLICULAR LYMPHOMA PATIENTS FROM A PHASE 2 STUDY

N. D. Wagner-Johnston , A. Viardot , A. M. Carella , G. Salles
Haematologica 100

2015
Bone marrow microenvironment and malignant B cells in human multiple myeloma

F. Caligaris-Cappio , D. Gottardi , A. Novarino , P. Ghia
Leukemia 8 ( 9) 1602 -1603

1994
Chronic lymphocytic leukemia (CLL)

Šárka Pospíšilová , E. Kimby , P. Ghia , C. Moreno

2015
Ex Vivo Lymph Node Native Microenvironment Assay Shows Novel Antiproliferative Activity For Idelalisib And Ibrutinib On Cll Cells

Juan Ballesteros , Lydia Scarfo , Mattias Mattsson , A. Xochelli
Haematologica 101 426 -426

1
2016
Distinct Homotypic B-Cell Receptor Interactions Shape The Outcome Of Chronic Lymphocytic Leukemia

S. Ntoufa , A. Tasdogan , M. Gounari , A. Agathangelidis
Haematologica 101 9 -9

2
2016